Carol Schafer
Board Member
Kura Oncology, Inc. (KURA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Carol Schafer
Carol Schafer is recorded as Board Member at Kura Oncology, Inc. (KURA). Kura Oncology, Inc. reported in an 8-K filed June 6, 2025 that Carol Schafer was appointed Class II director, effective June 5, 2025.
“(1) elected Helen Collins, M.D., Thomas Malley and Carol Schafer as Class II directors to hold office until our 2028 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified, or until their earlier death, resignation or removal;”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-06-05–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Kura Oncology, Inc.
Other people whose current roles at this company are on record from its filings.
- Troy Wilson CEO
- Jennifer Fulk CFO
- Marc Grasso CFO
- Troy E. Wilson, Ph.D., J.D. CFO, Board Member
- Kathleen Ford COO
- Thomas Doyle Chief Accounting Officer
- Carol A. Schafer Board Member
- Diane Parks Board Member
- Faheem Hasnain Board Member
- Helen Collins, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.